UK markets open in 21 minutes

Interpace Diagnostics Group, Inc. (IDXG)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.4225-0.1295 (-8.34%)
At close: 03:38PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
40,214
40,214
31,838
33,117
32,398
Cost of revenue
16,310
16,310
13,607
14,314
21,673
Gross profit
23,904
23,904
18,231
18,803
10,725
Operating expenses
Research development
636
636
703
1,493
2,795
Selling general and administrative
19,596
19,596
20,098
19,882
27,446
Total operating expenses
21,093
21,093
22,071
24,567
34,702
Operating income or loss
2,811
2,811
-3,840
-5,764
-23,977
Interest expense
1,008
1,008
1,008
1,040
549
Total other income/expenses net
-674
-674
-988
-938
-1,622
Income before tax
1,129
1,129
-5,836
-7,742
-26,148
Income tax expense
17
17
29
-705
53
Income from continuing operations
1,112
1,112
-5,865
-7,037
-26,201
Net income
802
802
-21,958
-14,943
-26,451
Net income available to common shareholders
802
802
-21,958
-14,943
-29,484
Basic EPS
-3.59
0.19
-5.18
-3.61
-7.32
Diluted EPS
-3.59
0.18
-5.18
-3.61
-7.32
Basic average shares
4,283
4,317
4,238
4,135
4,029
Diluted average shares
4,285
4,364
4,238
4,135
4,029